Ocular Toxicities in Patients Receiving Anticancer Therapy with Dr Asim Farooq
Dr Asim Farooq from The University of Chicago Medical Center in Chicago, Illinois, discusses common ocular toxicities associated with anticancer agents, including antibody-drug conjugates and EGFR, ALK, MEK and BRAF inhibitors. CME information and select publications here (http://www.researchtopractice.com/OncologyToday22OcularToxicities).
